Company intelligence / Profile preview

Jin Dun Medical

Shanghai, Shanghai, China

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Jin Dun Medical is a commercial-stage CRO/CDMO/API manufacturer serving domestic and international pharmaceutical companies, specializing in pharmaceutical intermediates, APIs, and custom synthesis for small molecules and peptides across metabolic, cardiovascular, oncologic, CNS, and anti-infective indications. The company operates ISO-qualified, GMP-compliant production facilities and offers process innovation, impurity research, and technology transfer services, but does not report its own clinical trial results as a service provider[1][3][5].

Therapeutic areas: EndocrinologyPsychiatryInfectious DiseasesCardiovascularOncologyNeurology
Modalities: Small moleculePeptides
Industry: Contract Research Organization

Partnerships

HansohHengruiHEC Pharm

Beyond the preview

Go deeper on Jin Dun Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jin Dun Medical.

Explore the full profile